Open Journal Systems
The Role of Real-World Evidence based Research in Advancing Global Health Outcomes
Abstract
Real World Evidence (RWE) based research plays a crucial role in advancing global health by providing large-scale, real-world data on disease patterns, treatment outcomes, and population health trends. In contrast to randomized clinical trials, registries examine very diverse populations over long periods of time. This allows for a greater understanding of both acute and chronic conditions. This is especially vital in global health as disparities in access to care and health outcomes remain widespread. RWE data can aid in early detection of public health issues, inform policymakers, and help allocate resources effectively across various areas. Additionally, registries improve representation by including populations that are overlooked in traditional research to facilitate identification and address health inequities. Overall, RWE based research serves as a powerful tool for improving health outcomes and promoting equity on a global scale.
Keywords
References
Gaye B. The bias in medical research: Africa carries a huge disease burden but is missing from clinical trials. The Conversation. May 3, 2026. doi:10.64628/AAJ.xy3ce7ccy
Hacker K. The Burden of Chronic Disease. mcp:iqo. 2024;8(1):112-119. doi:10.1016/j.mayocpiqo.2023.08.005
Simpson S, Wang W, Otahal P, Blizzard L, van der Mei IAF, Taylor BV. Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis. J Neurol Neurosurg Psychiatry. 2019;90(11):1193-1200. doi:10.1136/jnnp-2018-320189
Hwang S, Garcia-Dominguez MA, Fitzgerald KC, Saylor DR. Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level. Neurology. 2022;99(16):e1813-e1823. doi:10.1212/WNL.0000000000200962
Patient enrolment. MSBase. Accessed May 27, 2026. https://www.msbase.org/data-findings/patient-enrolment/
Naehrlich L. Expanding Cystic Fibrosis Registries to the Rest of the World. Pediatric Pulmonology. 2026;61(1):e71445. doi:10.1002/ppul.71445
Plessis J du. Access is not secured. SACFA. August 11, 2025. Accessed May 27, 2026. https://sacfa.org.za/action-access-not-secured/
Commissioner O of the. FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews. FDA. December 15, 2025. Accessed May 27, 2026. https://www.fda.gov/news-events/press-announcements/fda-eliminates-major-barrier-using-real-world-evidence-drug-and-device-application-reviews
Commissioner O of the. FDA use of Real-World Evidence in Regulatory Decision Making. FDA. Published online September 26, 2025. Accessed May 27, 2026. https://www.fda.gov/science-research/real-world-evidence/fda-use-real-world-evidence-regulatory-decision-making
Email this article 
